The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Open accessAbstract
The diagnosis of amyotrophic lateral sclerosis can be challenging due to its heterogeneity in clinical presentation and overlap with other neurological disorders. Diagnosis early in the disease course can improve outcomes as timely interventions can slow disease progression. An evolving awareness of disease genotypes and phenotypes and new diagnostic criteria, such as the recent Gold Coast criteria, could expedite diagnosis. Improved prognosis, such as that achieved with the survival model from the European Network for the Cure of ALS, could inform the patient and their family about disease course and improve end-of-life planning. Novel staging and scoring systems can help monitor disease progression and might potentially serve as clinical trial outcomes. Lastly, new tools, such as fluid biomarkers, imaging modalities, and neuromuscular electrophysiological measurements, might increase diagnostic and prognostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“monogenic ALS mutations may still exhibit incomplete penetrance or delayed onset [8]”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“as exposure to certain environmental factors might modify the risk the mutations confer [8].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationCedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Self-citationThe phenotypic variability of amyotrophic lateral sclerosis
Swinnen, B., & Robberecht, W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.184 · Cited by 647
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
Chiò, A., Calvo, A., Moglia, C., Mazzini, L., Mora, G., & PARALS study group (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.235952 · Cited by 626
Self-citationA proposal for new diagnostic criteria for ALS
Shefner, J. M., Al‐Chalabi, A., Baker, M. R., Cui, L., de Carvalho, M. A., Eisen, A., Großkreutz, J., Hardiman, O. M., Henderson, R. D., Matamala, J. M., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.04.005 · Cited by 622
Self-citationNovel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Chia, R., Chiò, A., & Traynor, B. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30401-5 · Cited by 592
Self-citation
Research works printed but not linked: 1
- Pinto-Grau, 2020, Patterns of language impairment in early ALS, Neurol Clin Pract, 11, e634
Cited by
Sorted by citations
Feldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01272-7 · Cited by 1,267
Self-citationNeurofilaments as biomarkers in neurological disorders — towards clinical application
Khalil, M., Teunissen, C. E., Lehmann, S., Otto, M., Piehl, F., Ziemssen, T., Bittner, S., Sormani, M. P., Gattringer, T., Abu‐Rumeileh, S., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00955-x · Cited by 503
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Goutman, S. A., Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00414-2 · Cited by 432
Self-citationInnate immune activation in neurodegenerative diseases
Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 176
Skeletal muscle in amyotrophic lateral sclerosis
Shefner, J. M., Musarò, A., Ngo, S. T., Lunetta, C., Steyn, F. J., Robitaille, R., de Carvalho, M. A., Rutkove, S. B., Ludolph, A. C., & Dupuis, L. (2023) · Brain · doi:10.1093/brain/awad202 · Cited by 110
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Goutman, S. A., Savelieff, M. G., Jang, D., Hur, J., & Feldman, E. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00867-2 · Cited by 110
Self-citationRecent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy
Wang, H., Guan, L., & Deng, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1170996 · Cited by 108
Nicoletti, A. S. Q., Baschi, R., Cicero, C. E., Iacono, S., Re, V. L., Luca, A., Schirò, G., & Monastero, R. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111821 · Cited by 79
Sex difference in human diseases: mechanistic insights and clinical implications
Shi, Y., Ma, J., Li, S., Liu, C., Liu, Y., Chen, J., Liu, N., Liu, S., & Huang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01929-7 · Cited by 91
Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances
Rizea, R. E., Corlatescu, A.-D., Costin, H. P., Dumitru, A. V., & Ciurea, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189966 · Cited by 76
Update on recent advances in amyotrophic lateral sclerosis
Riva, N., Domi, T., Pozzi, L., Lunetta, C., Schito, P., Spinelli, E. G., Cabras, S., Matteoni, E., Consonni, M., Bella, E. D., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12435-9 · Cited by 74
Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis
Vidovic, M., Müschen, L. H., Brakemeier, S., Machetanz, G., Naumann, M., & Castro‐Gomez, S. (2023) · Cells · doi:10.3390/cells12050736 · Cited by 73
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine
Agrawal, I., Lim, Y. S., Ng, S., & Ling, S. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00322-0 · Cited by 65
Thangadurai, M., Ajith, A., Budharaju, H., Sethuraman, S., & Sundaramurthi, D. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213135 · Cited by 61
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis
Chia, R., Moaddel, R., Kwan, J. Y., Rasheed, M., Ruffo, P., Landeck, N., Reho, P., Vasta, R., Calvo, A., Moglia, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03890-6 · Cited by 62
Self-citationWearable device and smartphone data quantify ALS progression and may provide novel outcome measures
Johnson, S. A., Karas, M., Burke, K. M., Strączkiewicz, M., Scheier, Z. A., Clark, A., Iwasaki, S., Lahav, A., Iyer, A., Onnela, J.-P. “., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00778-y · Cited by 53
Feng, R., Zhu, Q., Wang, A., Wang, H., Wang, J., Chen, P., Zhang, R., Liang, D., Teng, J., Ma, M., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03781-6 · Cited by 49
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
Fournier, C. N. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01271-2 · Cited by 45
Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis
Guo, K., Figueroa‐Romero, C., Noureldein, M. H., Murdock, B. J., Savelieff, M. G., Hur, J., Goutman, S. A., & Feldman, E. L. (2023) · Brain · doi:10.1093/brain/awad306 · Cited by 46
Self-citationNovel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Wu, Z., Yu, X., Zhang, S., He, Y., & Guo, W. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01368-x · Cited by 43
He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 44
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 46
Meyer, T., Dreger, M., Grehl, T., Weyen, U., Kettemann, D., Weydt, P., Günther, R., Lingor, P., Petri, S., Koch, J. C., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16379 · Cited by 38
Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C. V., Bursnall, M., Bradburn, M., Kumar, P., Turton, E. J., White, D. A., Serfaty, M. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00533-6 · Cited by 38
Self-citationChen, S., Cai, X., Lao, L., Wang, Y., Su, H., & Sun, H. (2024) · Aging and Disease · doi:10.14336/ad.2023.0524 · Cited by 40
Mohan, M., Mannan, A., Kakkar, C., & Singh, T. G. (2024) · Current Drug Targets · doi:10.2174/0113894501320839240918110656 · Cited by 37
Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
Phan, K., He, Y. Z., Bhatia, S., Pickford, R., McDonald, G., Mazumder, S., Timmins, H. C., Hodges, J. R., Piguet, O., Dzamko, N. L., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac340 · Cited by 36
Self-citationCGG repeat expansion in LRP12 in amyotrophic lateral sclerosis
Kume, K., Kurashige, T., Muguruma, K., Morino, H., Tada, Y., Kikumoto, M., Miyamoto, T., Akutsu, S. N., Matsuda, Y., Matsuura, S., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.05.014 · Cited by 32
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies
Pitarokoili, K., Gold, R., & Fisse, A. L. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001183 · Cited by 32
Almohmadi, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Abdelaziz, A. M., Jabir, M. S., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111349 · Cited by 35
Verde, E. M., Secco, V., Ghezzi, A., Mandrioli, J., & Carra, S. (2025) · Cells · doi:10.3390/cells14100680 · Cited by 35
Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles
Goutman, S. A., Boss, J., Iyer, G., Habra, H., Savelieff, M. G., Karnovsky, A., Mukherjee, B., & Feldman, E. L. (2023) · Muscle & Nerve · doi:10.1002/mus.27744 · Cited by 31
Self-citationChristidi, F., Argyropoulos, G. D., Karavasilis, E., Velonakis, G., Zouvelou, V., Kourtesis, P., Pantoleon, V., Tan, E. L., Daponte, A., Aristeidou, S., et al. (2023) · Life · doi:10.3390/life13020571 · Cited by 31
Goutman, S. A., Boss, J., Jang, D., Mukherjee, B., Richardson, R. J., Batterman, S., & Feldman, E. L. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332121 · Cited by 31
Self-citationPilčević, D., Djuric-Jovicic, M. D., Antonijević, M., Bačanin, N., Jovanović, L., Zivkovic, M. Z., Dragović, M., & Bisevac, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1267011 · Cited by 32
Organoids as preclinical models of human disease: progress and applications
Chen, B., Du, C., Wang, M., Guo, J., & Liu, X. (2024) · Medical Review · doi:10.1515/mr-2023-0047 · Cited by 31
Ovsepian, S. V., O’Leary, V. B., & Martı́nez, S. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02728-6 · Cited by 30
Guillot, S. J., Lang, C., Simonot, M., Beckett, D., Lulé, D. E., Balz, L. T., Knehr, A., Stuart‐Lopez, G., Vercruysse, P., Dieterle, S., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adm7580 · Cited by 29
González-Sánchez, M., Ramı́rez-Expósito, M. J., & Martı́nez-Martos, J. M. (2025) · Life · doi:10.3390/life15040647 · Cited by 31
Younger, D. S., & Brown, R. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00031-4 · Cited by 35
Akiyama, T., Koike, Y. M., Petrucelli, L., & Gitler, A. D. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.818 · Cited by 25
Bilirubin and Redox Stress in Age-Related Brain Diseases
Llido, J. P., Jayanti, S. D., Tiribelli, C., & Gazzin, S. (2023) · Antioxidants · doi:10.3390/antiox12081525 · Cited by 27
Dai, T., Lou, J., Kong, D., Li, J., Ren, Q., Chen, Y., Sun, S., Yun, Y., Sun, X., Yang, Y., et al. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00536-6 · Cited by 25
Upper limb movements as digital biomarkers in people with ALS
Strączkiewicz, M., Karas, M., Johnson, S. A., Burke, K. M., Scheier, Z. A., Royse, T. B., Calcagno, N., Clark, A., Iyer, A., Berry, J. D., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105036 · Cited by 24
Zhao, Y., Li, X., Wang, K., Iyer, G. R., Sakowski, S. A., Zhao, L., Teener, S. J., Bakulski, K. M., Dou, J., Traynor, B. J., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105383 · Cited by 24
Self-citationCuffaro, F., Lamminpää, I., Niccolai, E., & Amedei, A. (2024) · Nutrients · doi:10.3390/nu17010102 · Cited by 25
Causes of death among United States decedents with ALS : An eye toward delaying mortality
Larson, T. C., III, Goutman, S. A., Davis, B., Bove, F., Thakur, N. M., & Mehta, P. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51762 · Cited by 24
Self-citationGuo, X., Zhang, Z., Gu, J., Ke, P., Liu, J., Meng, Y., Zheng, W., Que, W., Fan, R., Luo, J., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106534 · Cited by 23
Agah, E., Mojtabavi, H., Behkar, A., Heidari, A., Ajdari, A., Shaka, Z., Mousavi, S. V., Firoozeh, N., Tafakhori, A., & Rezaei, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05767-7 · Cited by 28
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
Roberts, B., Theunissen, F., Mastaglia, F. L., Akkari, P. A., & Flynn, L. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169364 · Cited by 25
Motor Band Sign in Motor Neuron Diseases Using Magnetic Resonance Imaging: A Systematic Review
Mohammadi, S., & Ghaderi, S. (2023) · Acta Neurologica Scandinavica · doi:10.1155/2023/6677967 · Cited by 23
Zhu, Y., Zhang, Y., Li, M., Bai, J., Wang, H., Pang, X., Du, R., Wang, J., & Huang, X. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13618 · Cited by 22
Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases
Izenberg, A. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001345 · Cited by 22
Longitudinal Metabolomics in Amyotrophic Lateral Sclerosis Implicates Impaired Lipid Metabolism
Guo, K., Savelieff, M. G., Jang, D., Teener, S. J., Zhao, L., Hur, J., Goutman, S. A., & Feldman, E. L. (2025) · Annals of Neurology · doi:10.1002/ana.27208 · Cited by 21
Self-citationChanges to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995–2018)
Vasta, R., Mattei, F. D., Tafaro, S., Canosa, A., Manera, U., Grassano, M., Palumbo, F., Cabras, S., Matteoni, E., Pede, F. D., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213467 · Cited by 24
Self-citationThe future of ALS diagnosis and staging: where do we go from here?
Genge, A. L., & Chiò, A. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2150555 · Cited by 21
Self-citationKamalian, A., Foroughmand, I., Koski, L., Darvish, M., Saghazadeh, A., Kamalian, A., Razavi, S. Z. E., Abdi, S., Dehgolan, S. R., Fotouhi, A., et al. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127165 · Cited by 21
Microglia in brain aging: An overview of recent basic science and clinical research developments
Fan, H., Zhang, M., Wen, J., Wang, S., Yuan, M., Sun, H., Shu, L., Xu, Y., Pu, Y., & Cai, Z. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.37.20220220 · Cited by 23
Aousji, O., Feldengut, S., Antonucci, S., Schön, M., Boeckers, T. M., Matschke, J., Mawrin, C., Ludolph, A. C., Tredici, K. D., Roselli, F., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01616-8 · Cited by 21
Occupational history associates with ALS survival and onset segment
Goutman, S. A., Boss, J., Godwin, C., Mukherjee, B., Feldman, E. L., & Batterman, S. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2127324 · Cited by 21
Self-citationC9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?
Sellier, C., Corcia, P., Vourc’h, P., & Dupuis, L. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.03.008 · Cited by 24
Dharmadasa, T., Pavey, N., Tu, S., Menon, P., Huynh, W., Mahoney, C., Timmins, H. C., Higashihara, M., van den Bos, M. A. J., Shibuya, K., et al. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.04.010 · Cited by 20
Self-citationZhang, Q., Lin, J., Wang, Y., Chen, L., Ding, Y., Zheng, F., Song, H., Lv, A., Li, Y., Guo, Q., et al. (2024) · Brain Pathology · doi:10.1111/bpa.13261 · Cited by 19
Mitra, J., Kodavati, M. M., Dharmalingam, P., Guerrero, E. N., Rao, K. S. J., Garruto, R. M., & Hegde, M. L. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01962-9 · Cited by 19
Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
Wen, T., & Zhang, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1197094 · Cited by 19
Peripheral Immune Profiles Predict ALS Progression in an Age- and Sex-Dependent Manner
Murdock, B. J., Zhao, B., Pawlowski, K. D., Famie, J. P., Piecuch, C. E., Webber‐Davis, I. F., Teener, S. J., Feldman, E. L., Zhao, L., & Goutman, S. A. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200241 · Cited by 19
Self-citationCorcia, P., Guy, N., Pradat, P., Soriani, M., Verschueren, A., & Couratier, P. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2375330 · Cited by 18
Sharma, R., Mehan, S., Khan, Z., Gupta, G. D., & Narula, A. S. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105876 · Cited by 19
Creatine Kinase MB Isoenzyme Is a Complementary Biomarker in Amyotrophic Lateral Sclerosis
Kittipeerapat, N., Fabian, R., Bernsen, S., Weydt, P., & Castro‐Gomez, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411682 · Cited by 18
Seki, S., Kitaoka, Y., Kawata, S., Nishiura, A., Uchihashi, T., Hiraoka, S.-I., Yokota, Y., Isomura, E. T., Kogo, M., & Tanaka, S. (2023) · Biomedicines · doi:10.3390/biomedicines11112967 · Cited by 18
Geraci, J., Bhargava, R., Qorri, B., Leonchyk, P., Cook, D. J., Cook, M., Sie, F., & Pani, L. (2024) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2023.1199736 · Cited by 19
Karas, M., Olsen, J. M., Strączkiewicz, M., Johnson, S. A., Burke, K. M., Iwasaki, S., Lahav, A., Scheier, Z. A., Clark, A., Iyer, A. S., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52050 · Cited by 18
Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis
Hannaford, A., Byth, K., Pavey, N., Henderson, R. D., Mathers, S., Needham, M., Schultz, D., Menon, P., Kiernan, M. C., & Vucic, S. (2023) · Muscle & Nerve · doi:10.1002/mus.27736 · Cited by 16
Self-citationClinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis
Yuan, D., Jiang, S., & Xu, R. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2399962 · Cited by 17
Jiao, L., Yang, J., Wang, W., Liu, X., Fu, Y., & Fan, D. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1515252 · Cited by 18
Cathepsins in Neurological Diseases
Lewandowski, D., Konieczny, M., Różycka, A., Chrzanowski, K., Owecki, W., Kalinowski, J., Stepura, M., Jagodziński, P. P., & Dorszewska, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167886 · Cited by 17
Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis
Donini, L., Tanel, R., Zuccarino, R., & Basso, M. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.09.002 · Cited by 20
Grossini, E., Marchi, F. D., Venkatesan, S., Mele, A., Ferrante, D., & Mazzini, L. (2023) · Antioxidants · doi:10.3390/antiox12101887 · Cited by 17
The role of statins in amyotrophic lateral sclerosis: protective or not?
Al-Kuraishy, H. M., Jabir, M. S., Sulaiman, G. M., Mohammed, H. A., Al-Gareeb, A. I., Albuhadily, A. K., Jawad, S. F., Swelum, A. A., & Abomughaid, M. M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1422912 · Cited by 17
Vidovic, M., Lapp, H. S., Weber, C., Plitzko, L., Seifert, M., Steinacker, P., Otto, M., Hermann, A., & Günther, R. (2024) · Brain Communications · doi:10.1093/braincomms/fcae288 · Cited by 16
Chiò, A., Moglia, C., Canosa, A., Manera, U., Grassano, M., Vasta, R., Palumbo, F., Gallone, S., Brunetti, M., Barberis, M., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207367 · Cited by 16
Self-citationApplication of advanced biosensors in nervous system diseases
Meng, Z., Zhang, Y., Lu, Y., Yuan, F., Wang, J., Chen, J., Liu, J., Wang, G., & Zang, G. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240024 · Cited by 17
Sharma, R., Khan, Z., Mehan, S., Gupta, G. D., & Narula, A. S. (2024) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2024.108518 · Cited by 18
Tsitkov, S., Valentine, K., Kozareva, V., Donde, A., Frank, A. P., Lei, S., Workman, M. J., Lim, R. G., Wu, J., Wu, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47758-8 · Cited by 17
Álvarez‐Sánchez, E., Carbayo, Á., Valle‐Tamayo, N., Muñoz, L., Aumatell, J., Torres, S., Rubio‐Guerra, S., Castro, J. G., Selma‐González, J., Alcolea, D. A., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03347-0 · Cited by 15
Meyer, T., Boentert, M., Großkreutz, J., Weydt, P., Bernsen, S., Reilich, P., Steinbach, R., Rödiger, A., Wolf, J., Weyen, U., et al. (2025) · Neurological Research and Practice · doi:10.1186/s42466-025-00389-w · Cited by 15
Face-based machine learning diagnostics: applications, challenges and opportunities
Song, J., He, M., Zheng, X., Zhang, Y., Bi, C., Feng, J., Du, J., Li, H., & Shen, B. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-025-11246-2 · Cited by 15
From RIPK1 to Necroptosis: Pathogenic Mechanisms in Neurodegenerative Diseases
Kang, A., Qiao, Y., Pan, S., Yan, F., Chen, H., & Bai, Y. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04448-1 · Cited by 17
Bono, N., Fruzzetti, F., Farinazzo, G., Candiani, G., & Marcuzzo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125671 · Cited by 20
Anti-inflammatory effect of curcumin on neurological disorders: a narrative review
Zhou, B., & Hu, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1658115 · Cited by 19
Verde, F., Ferrari, I., Maranzano, A., Ciusani, E., Torre, S., Milone, I., Colombo, E., Doretti, A., Peverelli, S., Ratti, A., et al. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06604-3 · Cited by 15
Digital Alternative Communication for Individuals with Amyotrophic Lateral Sclerosis: What We Have
Fernandes, F. R. D. S., Barbalho, I. M. P., Júnior, A. T. F., Alves, L. P. C. F., Nagem, D. A. P., Lins, H. W. D. C., Júnior, E. A., Coutinho, K. D., de Morais, A. H. F., dos Santos, J. P. Q., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165235 · Cited by 15
Tang, J., Kang, Y., Zhou, Y., Chen, Q., Lan, J., Liu, X., & Peng, Y. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110760 · Cited by 16
Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS
Calma, A. D., van den Bos, M. A. J., Pavey, N., Silva, C. S., Menon, P., & Vucic, S. (2024) · Brain Sciences · doi:10.3390/brainsci14080760 · Cited by 15
Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis
Calvo, A. C., Valledor-Martín, I., Moreno‐Martínez, L., Toivonen, J. M., & Osta, R. (2022) · Genes · doi:10.3390/genes13050865 · Cited by 15
Noto, Y., Kitaoji, T., Watanabe, K., & Mizuno, T. (2023) · Muscle & Nerve · doi:10.1002/mus.27824 · Cited by 14
Umar, T. P., Jain, N., Papageorgakopoulou, M. A., Shaheen, R. S., AlSamhori, J. F., Muzzamil, M., & Kostiks, A. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2334836 · Cited by 15
miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis
Hur, J., Paez-Colasante, X., Figueroa‐Romero, C., Lo, T., Barmada, S. J., Paulsen, M. T., Ljungman, M. E., Alakwaa, F., Savelieff, M. G., Goutman, S. A., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac250 · Cited by 14
Self-citationYang, X., Gao, X., Jiang, X., Yue, K., & Luo, P. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00462 · Cited by 15
Artificial intelligence models using F-wave responses predict amyotrophic lateral sclerosis
Martinez‐Thompson, J. M., Mazurek, K. A., Parra‐Cantu, C., Naddaf, E., Gogineni, V., Botha, H., Jones, D. T., Laughlin, R. S., Barnard, L. R., & Staff, N. P. (2025) · Brain · doi:10.1093/brain/awaf014 · Cited by 14
Metadata
- Authors
- Goutman, S. A., Hardiman, O., Al-Chalabi, A., Chió, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L.
- Affiliations
- University of Michigan (US)
- Trinity College Dublin (IE)
- University of Turin (IT)
- The University of Sydney (AU)
- Corresponding author
- Feldman, Eva L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 21
- Issue
- 5
- Pages
- 480-493
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC9513753
- OpenAlex
- W4220676470
- Cited by
- 493
- References
- 107
- Citations by year
- 2026: 115 · 2025: 125 · 2024: 143 · 2023: 82 · 2022: 28
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Funders
- Seventh Framework Programme (259867)
- National Institute for Health Research Imperial Biomedical Research Centre
- Medical Research Council (MR/R024804/1, MR/L501529/1)
- Science Foundation Ireland (16/RC/3948, 13/RC2015)
- National Institute for Health Research (NIHR202421)
- National Institute of Neurological Disorders and Stroke (R01NS120926, R01NS127188)
- South London and Maudsley NHS Foundation Trust
- Ministero della Salute
- ALS Association
- National Institute of Environmental Health Sciences (R01ES030049, K23ES027221)
- Health Research Board
- National Health and Medical Research Council (APP1132524, APP1153439, APP1156093)
- University of Michigan
- Sinai Medical Staff Foundation
- Thierry Latran Foundation
- Horizon 2020
- Economic and Social Research Council (ES/L008238/1)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2017SNW5MB)
- EU Joint Programme – Neurodegenerative Disease Research
- Motor Neurone Disease Association
- King's College London
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- amyotrophic lateral sclerosis, diagnosis, prognosis, survival models, disease staging, disease progression, fluid biomarkers, neuroimaging, phenotypes, end-of-life planning
- MeSH terms
- Amyotrophic Lateral Sclerosis, Electromyography, Humans, Prognosis, Biomarkers, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
